Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BRAF Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study.
Mas L, Bachet JB, Taly V, Bouché O, Taieb J, Cohen R, Meurisse A, Normand C, Gornet JM, Artru P, Louafi S, Thirot-Bidault A, Baumgaertner I, Coriat R, Tougeron D, Lecomte T, Mary F, Aparicio T, Marthey L, Blons H, Vernerey D, Laurent-Puig P. Mas L, et al. Cancers (Basel). 2019 Jul 17;11(7):998. doi: 10.3390/cancers11070998. Cancers (Basel). 2019. PMID: 31319569 Free PMC article.
Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohort.
Auclin E, Marthey L, Abdallah R, Mas L, Francois E, Saint A, Cunha AS, Vienot A, Lecomte T, Hautefeuille V, de La Fouchardière C, Sarabi M, Ksontini F, Forestier J, Coriat R, Fabiano E, Leroy F, Williet N, Bachet JB, Tougeron D, Taieb J. Auclin E, et al. Among authors: mas l. Br J Cancer. 2021 Jun;124(12):1941-1948. doi: 10.1038/s41416-021-01341-w. Epub 2021 Mar 26. Br J Cancer. 2021. PMID: 33772154 Free PMC article.
Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective study.
Bachet JB, Laurent-Puig P, Meurisse A, Bouché O, Mas L, Taly V, Cohen R, Gornet JM, Artru P, Louafi S, Thirot-Bidault A, Baumgaertner I, Coriat R, Tougeron D, Lecomte T, Mary F, Aparicio T, Marthey L, Blons H, Vernerey D, Taieb J. Bachet JB, et al. Among authors: mas l. Eur J Cancer. 2023 Aug;189:112934. doi: 10.1016/j.ejca.2023.05.022. Epub 2023 Jun 7. Eur J Cancer. 2023. PMID: 37390800
Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinoma.
Mas L, Cros J, Svrcek M, Van Laethem JL, Emile JF, Rebours V, Nicolle R, Bachet JB. Mas L, et al. Clin Res Hepatol Gastroenterol. 2023 Apr;47(4):102108. doi: 10.1016/j.clinre.2023.102108. Epub 2023 Mar 5. Clin Res Hepatol Gastroenterol. 2023. PMID: 36878461 Free article.
[Neoadjuvant treatment for rectal cancer].
Bachet JB, Benoist S, Mas L, Huguet F. Bachet JB, et al. Among authors: mas l. Bull Cancer. 2021 Sep;108(9):855-867. doi: 10.1016/j.bulcan.2021.03.018. Epub 2021 Jun 14. Bull Cancer. 2021. PMID: 34140155 Review. French.
[Advanced GIST: Which treatments in 2022?].
Mas L, Bachet JB. Mas L, et al. Bull Cancer. 2022 Oct;109(10):1082-1087. doi: 10.1016/j.bulcan.2022.06.009. Epub 2022 Aug 4. Bull Cancer. 2022. PMID: 35934543 French.
90 results